down arrow

Colgate-Palmolive Co.

  • Market Cap: Large Cap
  • Industry: FMCG
  • ISIN: US1941621039
USD
77.60
-0.6 (-0.77%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

77.5678.50

52 Week

74.55100.18
Valuation
Technical
Day's Volume

CASH

1.85 M

Shareholding (Jun 2025)

FII

21.79%

Held by 560 FIIs

DII

48.54%

Held by 104 DIIs

Promoter

0.04%

How big is Colgate-Palmolive Co.?

22-Jun-2025

As of Jun 18, Colgate-Palmolive Co. has a market capitalization of $126.41 billion, with net sales of $19.95 billion and a net profit of $3.05 billion for the latest four quarters.

As of Jun 18, Colgate-Palmolive Co. has a market capitalization of 126,407.02 million, classifying it as a Large Cap company.<BR><BR>As of Jun 18, the company reported net sales of 19,946.00 million and a net profit of 3,048.00 million for the latest four quarters.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds of 212.00 million and total assets amounting to 16,046.00 million.

Read More

What does Colgate-Palmolive Co. do?

22-Jun-2025

Colgate-Palmolive Company is a large-cap consumer products firm in the FMCG industry, reporting net sales of $4.91 billion and a net profit of $726 million as of March 2025. Key metrics include a P/E ratio of 41.00 and a dividend yield of 1.31%.

Overview:<BR>Colgate-Palmolive Company is a consumer products company operating in the FMCG industry, with a market capitalization in the large-cap bracket.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 4,911 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 726 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 126,407.02 Million (Large Cap)<BR><BR>Key Metrics:<BR>P/E: 41.00 <BR>Dividend Yield: 1.31% <BR>Debt Equity: 19.17 <BR>Return on Equity: 868.55% <BR>Price to Book: 348.23<BR><BR>Contact Details:<BR>Address: 300 PARK AVE, NEW YORK NY: 10022-7402 <BR>Tel: 1 212 3102000 <BR>Website: https://www.colgate.com/

Read More

Who are in the management team of Colgate-Palmolive Co.?

22-Jun-2025

As of March 2022, the management team of Colgate-Palmolive Co. is led by Mr. Noel Wallace as Chairman, President, and CEO, with Mr. Stephen Sadove as Lead Independent Director, alongside independent directors including Mr. John Bilbrey, Mr. John Cahill, Ms. Lisa Edwards, and Dr. Helene Gayle.

As of March 2022, the management team of Colgate-Palmolive Co. includes Mr. Noel Wallace, who serves as the Chairman of the Board, President, and Chief Executive Officer. Additionally, Mr. Stephen Sadove holds the position of Lead Independent Director. The board also includes independent directors: Mr. John Bilbrey, Mr. John Cahill, Ms. Lisa Edwards, and Dr. Helene Gayle.

Read More

Is Colgate-Palmolive Co. technically bullish or bearish?

20-Sep-2025

As of September 3, 2025, Colgate-Palmolive Co. is in a bearish trend, indicated by bearish signals from the MACD, Bollinger Bands, and moving averages, while underperforming the S&P 500 with a year-to-date return of -10.32%.

As of 3 September 2025, the technical trend for Colgate-Palmolive Co. has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength indicated by the weekly MACD and Bollinger Bands both showing bearish signals. The daily moving averages also confirm a bearish trend. The KST is bearish on the weekly and mildly bearish on the monthly, while the Dow Theory indicates a mildly bearish stance on both time frames. The OBV shows a mildly bullish signal on the weekly but is bearish on the monthly, suggesting some divergence in volume trends.<BR><BR>In terms of performance, Colgate-Palmolive has underperformed the S&P 500 across multiple periods, with a year-to-date return of -10.32% compared to the S&P 500's 12.22%, and a one-year return of -20.98% versus the S&P 500's 17.14%.

Read More

Is Colgate-Palmolive Co. overvalued or undervalued?

11-Nov-2025

As of November 7, 2025, Colgate-Palmolive Co. is considered overvalued with a valuation grade of expensive, reflected by a high P/E ratio of 41 and poor stock performance, having underperformed the S&P 500 with a year-to-date return of -13.68%.

As of 7 November 2025, the valuation grade for Colgate-Palmolive Co. has moved from fair to expensive, indicating that the company is overvalued. Key valuation ratios highlight this assessment, with a P/E ratio of 41, a Price to Book Value of 354.55, and an EV to EBITDA of 26.86. In comparison to peers, Procter & Gamble Co. has a P/E of 38.51 and an EV to EBITDA of 28.49, suggesting that Colgate-Palmolive's valuation is relatively high.<BR><BR>The company's recent stock performance also reinforces this valuation perspective, as it has underperformed against the S&P 500 with a year-to-date return of -13.68% compared to the index's 14.40%. Overall, the combination of high valuation ratios and poor stock performance suggests that Colgate-Palmolive Co. is currently overvalued.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in Jun 25

  • INTEREST COVERAGE RATIO(Q) Lowest at 1,783.1
  • INVENTORY TURNOVER RATIO(HY) Lowest at 3.9 times
  • DEBTORS TURNOVER RATIO(HY) Lowest at 11.12 times
2

With ROE of 868.55%, it has a fair valuation with a 354.55 Price to Book Value

3

High Institutional Holdings at 86.65%

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

FMCG

stock-summary
Market cap

USD 119,889 Million (Large Cap)

stock-summary
P/E

41.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.39%

stock-summary
Debt Equity

10.46

stock-summary
Return on Equity

447.93%

stock-summary
Price to Book

170.78

Revenue and Profits:
Net Sales:
5,110 Million
(Quarterly Results - Jun 2025)
Net Profit:
773 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.25%
0%
-7.25%
6 Months
-13.97%
0%
-13.97%
1 Year
-18.15%
0%
-18.15%
2 Years
-1.75%
0%
-1.75%
3 Years
-0.73%
0%
-0.73%
4 Years
1.08%
0%
1.08%
5 Years
-8.74%
0%
-8.74%

Colgate-Palmolive Co. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Colgate-Palmolive Co. overvalued or undervalued?

As of 7 November 2025, the valuation grade for Colgate-Palmolive Co. has moved from fair to expensive, indicating that the company is overvalued. Key valuation ratios highlight this assessment, with a P/E ratio of 41, a Price to Book Value of 354.55, and an EV to EBITDA of 26.86. In comparison to peers, Procter & Gamble Co. has a P/E of 38.51 and an EV to EBITDA of 28.49, suggesting that Colgate-Palmolive's valuation is relatively high. The company's recent stock performance also reinforces this valuation perspective, as it has underperformed against the S&P 500 with a year-to-date return of -13.68% compared to the index's 14.40%. Overall, the combination of high valuation ratios and poor stock performance suggests that Colgate-Palmolive Co. is currently overvalued....

Read More

Is Colgate-Palmolive Co. overvalued or undervalued?

As of 7 November 2025, the valuation grade for Colgate-Palmolive Co. moved from fair to expensive. The company appears overvalued based on its elevated valuation ratios, including a P/E ratio of 41, a Price to Book Value of 354.55, and an EV to EBITDA of 26.86. In comparison, Procter & Gamble Co. has a P/E of 38.51 and an EV to EBITDA of 28.49, indicating that Colgate-Palmolive is trading at a premium relative to its peer. Despite a strong ROE of 868.55% and a solid ROCE of 60.76%, these figures do not justify the high valuation ratios, suggesting that the stock may be priced too high given its performance metrics. Over the past year, Colgate-Palmolive has underperformed the S&P 500, with a return of -13.23% compared to the index's 12.65%, reinforcing the notion that the stock is currently overvalued....

Read More

Is Colgate-Palmolive Co. overvalued or undervalued?

As of 7 November 2025, the valuation grade for Colgate-Palmolive Co. has moved from fair to expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 41, a Price to Book Value of 354.55, and an EV to EBITDA of 26.86, all of which are significantly higher than its peers, such as Procter & Gamble Co., which has a P/E of 38.51 and an EV to EBITDA of 28.49. Given these metrics, Colgate-Palmolive Co. appears to be overvalued in comparison to its industry peers. Additionally, the stock has underperformed relative to the S&P 500, with a year-to-date return of -13.36% compared to the index's 14.40%, reinforcing the notion of overvaluation....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.64%
EBIT Growth (5y)
2.79%
EBIT to Interest (avg)
21.96
Debt to EBITDA (avg)
1.53
Net Debt to Equity (avg)
19.17
Sales to Capital Employed (avg)
2.21
Tax Ratio
22.70%
Dividend Payout Ratio
56.42%
Pledged Shares
0
Institutional Holding
86.65%
ROCE (avg)
56.03%
ROE (avg)
997.38%
Valuation key factors
Factor
Value
P/E Ratio
41
Industry P/E
Price to Book Value
354.55
EV to EBIT
30.50
EV to EBITDA
26.86
EV to Capital Employed
18.53
EV to Sales
6.80
PEG Ratio
3.10
Dividend Yield
1.29%
ROCE (Latest)
60.76%
ROE (Latest)
868.55%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 181 Schemes (29.62%)

Foreign Institutions

Held by 560 Foreign Institutions (21.79%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 4.05% vs -0.67% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 6.47% vs -6.80% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,110.00",
          "val2": "4,911.00",
          "chgp": "4.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,266.00",
          "val2": "1,238.00",
          "chgp": "2.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "71.00",
          "val2": "66.00",
          "chgp": "7.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-9.00",
          "val2": "-86.00",
          "chgp": "89.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "773.00",
          "val2": "726.00",
          "chgp": "6.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "218.20%",
          "val2": "222.00%",
          "chgp": "-0.38%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 3.31% vs 8.29% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 24.20% vs 24.81% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "20,101.00",
          "val2": "19,457.00",
          "chgp": "3.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,988.00",
          "val2": "4,698.00",
          "chgp": "6.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "292.00",
          "val2": "287.00",
          "chgp": "1.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-85.00",
          "val2": "-328.00",
          "chgp": "74.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,049.00",
          "val2": "2,455.00",
          "chgp": "24.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "218.00%",
          "val2": "212.30%",
          "chgp": "0.57%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
5,110.00
4,911.00
4.05%
Operating Profit (PBDIT) excl Other Income
1,266.00
1,238.00
2.26%
Interest
71.00
66.00
7.58%
Exceptional Items
-9.00
-86.00
89.53%
Consolidate Net Profit
773.00
726.00
6.47%
Operating Profit Margin (Excl OI)
218.20%
222.00%
-0.38%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 4.05% vs -0.67% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 6.47% vs -6.80% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
20,101.00
19,457.00
3.31%
Operating Profit (PBDIT) excl Other Income
4,988.00
4,698.00
6.17%
Interest
292.00
287.00
1.74%
Exceptional Items
-85.00
-328.00
74.09%
Consolidate Net Profit
3,049.00
2,455.00
24.20%
Operating Profit Margin (Excl OI)
218.00%
212.30%
0.57%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 3.31% vs 8.29% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 24.20% vs 24.81% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Colgate-Palmolive Co. stock-summary
stock-summary
Colgate-Palmolive Co.
FMCG
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company's oral care products include Colgate Total, Colgate Sensitive Pro-Relief, Colgate Max Fresh and Colgate Optic White. The Company is also engaged in various product categories of the personal care market with operations in liquid hand soap, which it sells under the Palmolive, Protex and Softsoap brands. The Company manufactures and markets a range of products for the home care market, including Palmolive and Ajax dishwashing liquids, Fabuloso and Ajax household cleaners and Murphy's Oil Soap. The Company, through its Hill's Pet Nutrition segment (Hill's), manufactures pet nutrition products for dogs and cats.
Company Coordinates stock-summary
Company Details
300 PARK AVE , NEW YORK NY : 10022-7402
stock-summary
Tel: 1 212 3102000
stock-summary
https://www.colgate.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."